ACTO Launches CxZone: The Future of AI-Based Training in Pharma
In a significant advancement for the pharmaceutical industry, ACTO has announced the launch of
CxZone, the first and only AI-driven role-play simulation solution tailored specifically for pharmaceutical professionals. This innovative platform is integrated with Veeva PromoMats and MedComms, providing a specialized training environment aimed at enhancing clinical fluency, mastering product messaging, and fostering continuous improvement through gamification.
Understanding CxZone
CxZone is designed for field teams to sharpen their clinical conversation skills in an environment that is fast-paced, flexible, and rich in feedback. Unlike traditional training tools, CxZone offers a judgment-free atmosphere where field representatives and Medical Science Liaisons (MSLs) can practice discussions with instant feedback that aligns with their company's unique sales processes and coaching models.
Key Benefits of CxZone
- - Customized Scenarios: Users can create practice scenarios based on automatically synced content from Veeva PromoMats and MedComms, ensuring that all training materials are current and compliant.
- - Focus on Clinical Fluency: CxZone emphasizes the development of fluency in clinical discussions, which is crucial for effectively communicating with healthcare professionals (HCPs).
- - Gamified Experience: The platform turns training into an engaging experience, with automated scoring, practice streaks, and individual performance trends to enhance user engagement.
Unique Features
1.
Realistic Avatars: Users can customize their professional avatars to simulate interactions with various types of HCPs, adapting to different therapeutic areas and emotional states.
2.
Personalized AI Simulations: The AI engine generates simulations that reflect each user's unique competencies, strengths, and weaknesses, allowing for relevant and applicable practice.
3.
Compliance and Security: CxZone is designed to meet SOC 2 Type II certification standards, ensuring that all training data is secure and compliant with FDA regulations.
Industry Reception
Sheryl Bisson, Senior Director of Training and Development at Johnson & Johnson Vision, expressed enthusiasm for CxZone, noting that the platform truly represents the dynamic nature of real-world interactions between field teams and HCPs. She emphasized that it would significantly boost the confidence and skills of representatives, making a substantial impact on every interaction.
Parth Khanna, CEO of ACTO, highlighted the challenges faced in the life sciences sector, such as limited access to HCPs and inconsistent training methods. With CxZone, he aims to address these issues head-on, emphasizing the need to develop a more effective way of practicing role play that is integrated with real-world scenarios.
Future Developments
Looking ahead, ACTO plans to introduce the
My HCP feature, which will allow users to practice with digital twins of their actual customers by integrating specific data from Veeva Vault CRM. This feature will include details about prescription behaviors, hospital affiliations, patient volume estimates, and participation in speaker programs, enabling a more nuanced approach to training.
By tailoring practice sessions to each HCP relationship, representatives can refine their approach, anticipating objections and strengthening their clinical communication skills.
Conclusion
CxZone is now available for companies in the life sciences sector looking to enhance customer experience and improve sales team performance during critical interactions. ACTO's commitment to marrying human intelligence with empathetic AI aims to ensure that field teams remain competent, confident, and credible in face-to-face encounters with healthcare professionals. For more information or to request a demonstration, visit
www.acto.com/CxZone. Follow ACTO on LinkedIn for the latest news and updates.
About ACTO
ACTO is a platform for intelligent field excellence designed for the life sciences sector, unifying human intelligence with empathetic AI to improve customer interactions and brand performance. As a validated platform compliant with FDA regulations, ACTO stands as a trusted partner for achieving intelligent field excellence in life sciences.